Effect of Spinal Manipulation on Vulvar Pain (SpManipPP)

March 28, 2020 updated by: University of Mary Hardin-Baylor

The Effect of Thoracic Spinal Manipulation on Vulvar Vestibule Pain: a Controlled Clinical Study

The purpose of the study is to determine the effect of thoracic spine manipulation on vestibule pain as determined by sensory testing (q-tip and pressure algometry) in a group of women with provoked vestibulodynia (PVD). The objective is to compare the immediate effect of manipulation and sham manipulation on the results of sensory testing of the external vulva, or vestibule.

Study Overview

Detailed Description

PRE-SCREENING: Participants expressing interest in this study will be interviewed to determine if eligibility criteria to participate in this study are met. If that is the case, the participant will then be invited to attend the familiarization and study session and informed of the need to refrain from alcohol use and keep medication regiment consistent in the 24 hours prior to the study appointment.

FAMILIARIZATION and CONSENT: During this session, the study protocol will be described and a written explanation of the study provided to the participant. After any questions have been addressed, the participant will sign the informed consent statement. Next, the participant will complete demographic and health questionnaires, which will be reviewed by the investigators to ensure eligibility criteria are met. If qualified,the participant will complete additional questionnaires that ask about pain, other symptoms of the pelvis and perineum and about feelings of anxiety and depression. Along with the questionnaires, a pelvic and lower extremity secondary screening examination will be performed as described below.

SECONDARY SCREEN and BASELINE TESTING: During the lower extremity screening examination, the participant will be asked to bend and straighten their spine, stretch in specific ways with the spine and legs and report if these motions provoked discomfort or pain. The pelvic exam and baseline testing is to ensure that the participant has pain in the perineum (area that is wiped after toileting). This will be tested in 2 ways, one using a sterile cotton tipped swab (q-tip test) and the other with a pressure sensing device called an algometer. One trained pelvic floor Physical Therapist (PT1) investigator will perform these tests. While investigator PT1 waits outside, the participant will undress from the waist down then lay under a sheet. PT1 will enter and perform the sensory tests during which the participant's pelvic floor and vestibule will be exposed in a similar manner to receiving a gynecologic exam. PT1 will use a q-tip to touch specific points around the vaginal opening (vestibule) and ask the participant to report any pain on a scale of 0 (none)-10 (worst). Next, a pressure algometer will be used to measure the amount of pressure tolerated on the most painful q-tip spot. This algometer has a flat disc, the size of a pencil eraser, that is covered to ensure cleanliness. Then the participant's lower body will be draped. Participant's with provoked pain are eligible to continue; those without are not eligible to continue in the study and will be done.

INTERVENTION and REPEAT BASELINE TESTING: The eligible participants are randomly assigned, by participant number, into one of the two testing groups. One group will receive a sham thoracic spine manipulation (ThS) and the other, a thoracic spine manipulation (ThM). During the thoracic intervention, the participant will lay on their back with arms crossed. The second PT (PT2), who is blinded to the results of the pain testing, will position one hand along the participant's thoracic spine and the other on the participant's crossed arms to apply a posterior motion to the participant's spine. This will be small motion that may be done quickly or slowly. After the technique, the participant will continue to rest on their back, while PT1 returns to repeat testing of the vestibule with the q-tip and algometer in the same manner as previously described. Then participation is finished.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: PATRICIA NELSON, PT, ScD
  • Phone Number: 254-295-4886
  • Email: pnelson@umhb.edu

Study Locations

    • Texas
      • Copperas Cove, Texas, United States, 76522
        • Recruiting
        • Integrity Rehab and Home Health
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Provides written and dated informed consent to participate in the study.
  • Is between the ages of 18-40 years.
  • Reports pain in the pelvis and/or vestibule (area that is wiped after using the toilet) that has been present for ≥ 6 weeks.
  • Has not had treatment for pelvic or vestibule pain in the 6 months prior to study participation.
  • Is willing and able to comply with study protocol.
  • Is healthy and free from disease, as determined by a health history questionnaire and screening exam.
  • Agrees to abstain from alcohol consumption 24 hours prior to the study protocol.
  • Reports a consistent regimen of pain medication use in the 6 weeks prior to the study protocol. This includes both prescription and over the counter medications.
  • Secondary Inclusion Criteria: demonstrates provoked vestibule pain to q-tip testing.

Exclusion Criteria:

  • Is currently pregnant, or attempting to become pregnant, as the intervention is contraindicated for this population.
  • Fails the health history, spine screen; or does not demonstrate provoked vestibule pain with q-tip test.
  • Has undergone any spine or pelvic girdle surgery in the 12 months prior to the study.
  • Has ever had sling/mesh placement to the pelvic region.
  • Has been diagnosed with osteopenia, osteoporosis, acute infection or arthritis flare, or other condition that could weaken the bony skeleton.
  • Has ever had a thoracic spine fracture.
  • Has had a change in any prescription or over-the-counter medications used for pain in the 6 weeks prior to the study.
  • Any other condition or adverse event in which study investigator recommend removal from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Thoracic Manipulation (ThM)
Will undergo spinal manipulation between pain assessment pre and post.
High velocity, small amplitude thrust treatment to spine that elicits a neurophysiologic response.
Sham Comparator: Sham thoracic treatment (ThS)
Sham manipulation between pain assessment pre and post
Hand placement on thorax without thrust.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Numeric Pain Rating Scale (NPRS) (0=none to 10=worst) report to cotton swab test in clock pattern
Time Frame: Pre and immediately post thoracic intervention. No longer term follow-up is planned.
Participant report on NPRS
Pre and immediately post thoracic intervention. No longer term follow-up is planned.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in peak pressure algometer
Time Frame: Pre and immediately post thoracic intervention. No longer term follow-up is planned
Nm2 pressure reading of provoked pain on most painful point
Pre and immediately post thoracic intervention. No longer term follow-up is planned

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: PATRICIA NELSON, PT, ScD, University of Mary Hardin-Baylor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2019

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

June 1, 2021

Study Registration Dates

First Submitted

July 1, 2019

First Submitted That Met QC Criteria

July 9, 2019

First Posted (Actual)

July 11, 2019

Study Record Updates

Last Update Posted (Actual)

March 31, 2020

Last Update Submitted That Met QC Criteria

March 28, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 6.7.2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No data sharing is planned

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vulvodynia

Clinical Trials on Thoracic manipulation

3
Subscribe